RETRACTED ARTICLE: Lycium barbarum polysaccharide alleviates IL-1β-evoked chondrogenic ATDC5 cell inflammatory injury through mediation of microRNA-124
We, the Editors and Publisher of the journal Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Huawei Ni, Guoxiu Wang, Yu Xu, Xiaomin Gu, Chengzhang Sun & Haibo Li (2019) Lycium barbarum polysaccharide alleviates IL-1β-evoked chondrogenic ATDC5 cell inflamma...
Saved in:
Main Authors: | Huawei Ni, Guoxiu Wang, Yu Xu, Xiaomin Gu, Chengzhang Sun, Haibo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1673765 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED ARTICLE: Lycium barbarum polysaccharide alleviates oxygen glucose deprivation-induced PC-12 cells damage by up-regulating miR-24
by: Shiqing Song, et al.
Published: (2019-12-01) -
Network Pharmacology and In Vivo Evaluation of Lycium barbarum Polysaccharide in Preventing Perfluorooctanoic Acid-Induced Damage in Broilers
by: Nana Gao, et al.
Published: (2025-10-01) -
Lycium barbarum-probiotic synergy alleviates chemotherapy-induced cancer-related fatigue via gut microbiota-metabolic axis regulation in mice
by: Hexiang Feng, et al.
Published: (2025-07-01) -
<i>Lycium barbarum</i> for Health and Longevity: A Review of Its Biological Significance
by: Tao Zhang, et al.
Published: (2025-05-01) -
Network pharmacology-based strategy to investigate pharmacological mechanisms of polysaccharide-free Lycium barbarum extract for chronic kidney disease treatment and verification in an animal model
by: Meiyou Liu, et al.
Published: (2025-12-01)